Table 3 Patients with local tumor recurrence
Patient No. (Age, sex) | Diagnosis (Grade) | Location | Size (cm)/depth | Radiation/ chemotherapy | Time interval between operation and local recurrence (months) | Modality of detection | Local recurrence | |||
|---|---|---|---|---|---|---|---|---|---|---|
Size (cm) | depth | USG findings | Palpable vs. nonpalpable at presentation | |||||||
#1 (67, M) | UPS (Grade 3) | Trunk | 4.0/intramuscular | +/+ | 9 | Short-term USG | 1.1 | Subcutaneous | Well-defined homogeneous hypoechoic mass | Nonpalpable |
#2 (61, F) | UPS (Grade 2) | Trunk | 4.5/Subcutaneous | +/+ | 9 | Short-term USG | 2.2 | Subcutaneous | Well-defined heterogeneous hypoechoic mass | Nonpalpable |
#3 (38, F) | Epithelioid sarcoma (Grade 2) | Hand | 1.3/Subcutaneous | +/- | 12 | Short-term USG | 0.9 | Subcutaneous | Partly defined heterogeneous hypoechoic mass | Nonpalpable |
#4 (45, F) | Extraskeletal myxoid chondrosarcoma (Grade 2) | Buttock | 10.5/Subcutaneous | -/- | 12 | Short-term USG | 0.8 | Subcutaneous | Two well-defined homogeneous hypoechoic mass | Nonpalpable |
#5 (50, F) | Sclerosing epithelioid fibrosarcoma (Grade 3) | Calf | 22.0/intramuscular | -/- | 3 | Short-term USG | 1.7 | Intermuscular | Well-defined homogeneous hypoechoic mass | Nonpalpable |
#6 (54, M) | MFS (Grade 2) | Calf | 4.3/Subcutaneous | +/- | 30 | Short-term USG | 1.5 | Subcutaneous | Partly defined homogeneous hypoechoic mass | Nonpalpable |
#7 (57, F) | Synovial sarcoma (Grade 2) | Hand | 2.8/intramuscular | +/+ | 30 | Short-term USG | 3.0 | Intramuscular | Well-defined homogeneous hypoechoic mass | Nonpalpable |
#8 (83, F) | UPS (Grade 2) | Thigh | 3.4/Subcutaneous | +/- | 27 | Routine protocol (MR) | 1.6 | Subcutaneous | Well-defined heterogeneous hypoechoic mass | Nonpalpable |
#9 (67, F) | UPS (Grade 3) | Axilla | 3.7/Subcutaneous | +/- | 27 | Routine protocol (P/E) | 0.8 | Subcutaneous | Well-defined homogenous hypoechoic mass | Palpable |
#10 (65, M) | MFS (Grade 2) | Calf | 5.6/Subcutaneous | +/- | 15 | Routine protocol (P/E) | 0.9 | Subcutaneous | Well-defined heterogeneous hypoechoic mass | Palpable |
#11 (61, F) | UPS (Grade 3) | Trunk | 8.0/Intramuscular | -/- | 15 | Routine protocol (MR) | 3.1 | Subcutaneous | Well-defined homogenous hypoechoic mass | Nonpalpable |
#12 (48, M) | UPS (Grade 3) | Thigh | 11.2/Intramuscular | +/- | 1 | Routine protocol (P/E) | 3.5 | Intramuscular | NAa | Palpable |
#13 (54, M) | UPS (Grade 3) | Calf | 1.5/Subcutaneous | +/- | 22 | Routine protocol (P/E) | 2.4 | Subcutaneous | Well-defined homogenous hypoechoic mass | Palpable |
#14 (58, F) | Angiosarcoma (Grade 2) | Forearm | 3.5/Subcutaneous | +/+ | 21 | Routine protocol (P/E) | NA† | Subcutaneous | NAb | Palpable |
#15 (61, M) | Undifferentiated spindle cell sarcoma (Grade 3) | Thigh | 11.5/Intramuscular | +/+ | 18 | Routine protocol (MR) | 5.0 | Intramuscular | Well-defined homogenous hypoechoic mass | Non-palpable |
#16 (47, F) | Undifferentiated spindle cell sarcoma (Grade 2) | Thigh | 5.6/Subcutaneous | -/- | 12 | Routine protocol (MR) | 1.3 | Subcutaneous | Well-defined heterogeneous hypoechoic mass | Nonpalpable |
#17 (55, M) | Undifferentiated spindle cell sarcoma (Grade 2) | Buttock | 3.7/Subcutaneous | -/- | 18 | Routine protocol (MR) | 1.7 | Intramuscular | Well-defined homogenous hypoechoic mass | Nonpalpable |
#18 (20, F) | Sclerosing/spindle cell rhabdomyosarcoma (Grade 3) | Thigh | 11.9/Intramuscular | +/+ | 36 | Routine protocol (MR) | 1.2 | Intramuscular | Well-defined homogenous hypoechoic mass | Nonpalpable |
#19 (70, F) | MFS (Grade 2) | Buttock | 10.7/Intramuscular | +/- | 24 | Routine protocol (MR) | 6.0 | Intramuscular | Partly-defined homogeneous hypoechoic mass | Nonpalpable |
#20 (46, M) | Synovial sarcoma (Grade 3) | Thigh | 8.2/Intramuscular | +/+ | 21 | Routine protocol (P/E) | 3.0 | Intermuscular | Several well-defined homogeneous hypoechoic mass | Palpable |